These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 8521809)
21. A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus. Xiong S; Borrego P; Ding X; Zhu Y; Martins A; Chong H; Taveira N; He Y J Virol; 2017 Jan; 91(1):. PubMed ID: 27795437 [TBL] [Abstract][Full Text] [Related]
22. Participation of two fusion peptides in measles virus-induced membrane fusion: emerging similarity with other paramyxoviruses. Samuel O; Shai Y Biochemistry; 2001 Feb; 40(5):1340-9. PubMed ID: 11170461 [TBL] [Abstract][Full Text] [Related]
23. The Tryptophan-Rich Motif of HIV-1 gp41 Can Interact with the N-Terminal Deep Pocket Site: New Insights into the Structure and Function of gp41 and Its Inhibitors. Zhu Y; Ding X; Yu D; Chong H; He Y J Virol; 2019 Dec; 94(1):. PubMed ID: 31619552 [TBL] [Abstract][Full Text] [Related]
24. Structural characterization of mumps virus fusion protein core. Liu Y; Xu Y; Lou Z; Zhu J; Hu X; Gao GF; Qiu B; Rao Z; Tien P Biochem Biophys Res Commun; 2006 Sep; 348(3):916-22. PubMed ID: 16904649 [TBL] [Abstract][Full Text] [Related]
25. Membrane fusion-inhibiting peptides do not inhibit influenza virus fusion or the Ca(2+)-induced fusion of negatively charged vesicles. Stegmann T J Biol Chem; 1993 Dec; 268(36):26886-92. PubMed ID: 8262922 [TBL] [Abstract][Full Text] [Related]
26. Membrane-anchored inhibitory peptides capture human immunodeficiency virus type 1 gp41 conformations that engage the target membrane prior to fusion. Melikyan GB; Egelhofer M; von Laer D J Virol; 2006 Apr; 80(7):3249-58. PubMed ID: 16537592 [TBL] [Abstract][Full Text] [Related]
27. Design of a peptide inhibitor that blocks the cell fusion mediated by glycoprotein 41 of human immunodeficiency virus type 1. Jin BS; Ryu JR; Ahn K; Yu YG AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1797-804. PubMed ID: 11118065 [TBL] [Abstract][Full Text] [Related]
28. Highly specific inhibition of leukaemia virus membrane fusion by interaction of peptide antagonists with a conserved region of the coiled coil of envelope. Lamb D; Schüttelkopf AW; van Aalten DM; Brighty DW Retrovirology; 2008 Aug; 5():70. PubMed ID: 18680566 [TBL] [Abstract][Full Text] [Related]
29. Peptide inhibitors of enveloped virus infection inhibit phospholipid vesicle fusion and Sendai virus fusion with phospholipid vesicles. Kelsey DR; Flanagan TD; Young J; Yeagle PL J Biol Chem; 1990 Jul; 265(21):12178-83. PubMed ID: 2165053 [TBL] [Abstract][Full Text] [Related]
30. A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled-coil formation. Rabenstein M; Shin YK Biochemistry; 1995 Oct; 34(41):13390-7. PubMed ID: 7577925 [TBL] [Abstract][Full Text] [Related]
31. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes. Pritsker M; Rucker J; Hoffman TL; Doms RW; Shai Y Biochemistry; 1999 Aug; 38(35):11359-71. PubMed ID: 10471286 [TBL] [Abstract][Full Text] [Related]
32. Mutational analysis of residues in the coiled-coil domain of human immunodeficiency virus type 1 transmembrane protein gp41. Weng Y; Weiss CD J Virol; 1998 Dec; 72(12):9676-82. PubMed ID: 9811701 [TBL] [Abstract][Full Text] [Related]
33. An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein. Piñón JD; Kelly SM; Price NC; Flanagan JU; Brighty DW J Virol; 2003 Mar; 77(5):3281-90. PubMed ID: 12584351 [TBL] [Abstract][Full Text] [Related]
34. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Wild C; Dubay JW; Greenwell T; Baird T; Oas TG; McDanal C; Hunter E; Matthews T Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12676-80. PubMed ID: 7809100 [TBL] [Abstract][Full Text] [Related]
35. Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B. Galdiero S; Vitiello M; D'Isanto M; Falanga A; Collins C; Raieta K; Pedone C; Browne H; Galdiero M J Gen Virol; 2006 May; 87(Pt 5):1085-1097. PubMed ID: 16603508 [TBL] [Abstract][Full Text] [Related]
36. A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41. Joshi SB; Dutch RE; Lamb RA Virology; 1998 Aug; 248(1):20-34. PubMed ID: 9705252 [TBL] [Abstract][Full Text] [Related]
37. Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial-approved membrane fusion inhibitor. Yu D; Ding X; Liu Z; Wu X; Zhu Y; Wei H; Chong H; Cui S; He Y J Biol Chem; 2018 Aug; 293(33):12703-12718. PubMed ID: 29929981 [TBL] [Abstract][Full Text] [Related]
38. Biochemistry and biophysics of HIV-1 gp41 - membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor design. Cai L; Gochin M; Liu K Curr Top Med Chem; 2011 Dec; 11(24):2959-84. PubMed ID: 22044229 [TBL] [Abstract][Full Text] [Related]
39. Peptide and non-peptide HIV fusion inhibitors. Jiang S; Zhao Q; Debnath AK Curr Pharm Des; 2002; 8(8):563-80. PubMed ID: 11945159 [TBL] [Abstract][Full Text] [Related]
40. Effect of dextran sulfate on fusion of Sendai virus with human erythrocyte ghosts. Ohki S; Arnold K; Srinivasakumar N; Flanagan TD Biomed Biochim Acta; 1991; 50(2):199-206. PubMed ID: 1652245 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]